Literature DB >> 2362331

The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study.

S Julius1, K Jamerson, A Mejia, L Krause, N Schork, K Jones.   

Abstract

The Tecumseh project investigates the evolution of hypertension in a healthy population. Of 946 subjects aged 18 through 38 years, 124 had clinic blood pressure readings higher than 140/90 mm Hg (the mean for borderline hypertensive subjects was 130/94 mm Hg). Compared with normotensive subjects, borderline hypertensive subjects had higher home blood pressures (mean, 12/7 mm Hg higher). Their childhood and postpubertal blood pressures were elevated (6/4 mm Hg higher than normal at age 6 years and 12/7 mm Hg higher than normal at age 21 years), and hypertensive target organ changes were detected. Borderline hypertensive subjects also had elevated minimal forearm resistance (0.22 U higher than normal), decreased stroke index (1.8 mL/m2 lower than normal), and impaired ventricular diastolic relaxation (mitral Doppler peak early diastolic blood flow [E] to peak late diastolic blood flow [A] ratio 0.13 lower than normal). Borderline hypertensive subjects had significant abnormalities in other coronary risk factors (cholesterol levels were 0.39 mmol/L higher, triglyceride levels were 0.45 mmol/L higher, high-density lipoprotein levels were 0.08 mmol/L lower, insulin levels were 38 pmol/L higher, and 16.5% more of them were overweight). Borderline hypertension is neither transient nor innocuous. Its association with other predictors of atherosclerosis calls for clinical attention.

Entities:  

Mesh:

Year:  1990        PMID: 2362331

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  28 in total

Review 1.  A sympathetic view of human obesity.

Authors:  Elisabeth A Lambert; Nora E Straznicky; Gavin W Lambert
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

Review 2.  The prognostic significance of heart rate for cardiovascular disease and hypertension.

Authors:  Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

Review 3.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

4.  Treatment of prehypertension: how soon is soon enough? What therapy should be used?

Authors:  Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

Review 5.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 6.  The DASH diet and insulin sensitivity.

Authors:  Alan L Hinderliter; Michael A Babyak; Andrew Sherwood; James A Blumenthal
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

7.  Risk of progression to hypertension in a low-income Mexican population with prehypertension and normal blood pressure.

Authors:  Aida Jimenez-Corona; Ruy Lopez-Ridaura; Michael P Stern; Clicerio Gonzalez-Villalpando
Journal:  Am J Hypertens       Date:  2007-09       Impact factor: 2.689

Review 8.  Cardiovascular risk factors in perspective.

Authors:  S G Carruthers
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

9.  Cholesterol screening in a community health promotion program: epidemiologic results from a biracial population.

Authors:  J E Muscat; C Axelrad; K Ray; R Weston; C Landers; D Vaccaro; M A Orlandi; N J Haley
Journal:  Public Health Rep       Date:  1994 Jan-Feb       Impact factor: 2.792

10.  Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

Authors:  D Giugliano; A Quatraro; A Minei; N De Rosa; L Coppola; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.